Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 140,670 | 177,549 | 187,540 | 151,791 | 139,915 |
| Marketable Securities | 0 | 0 | 0 | 1,072 | 5,397 |
| Receivables | 237,140 | 217,940 | 223,688 | 241,394 | 227,887 |
| Inventories | 191,083 | 188,373 | 185,041 | 179,731 | 179,496 |
| Other current assets | 58,347 | 50,778 | 52,298 | 43,431 | 57,955 |
| TOTAL | $627,240 | $634,640 | $648,567 | $617,419 | $610,650 |
| Non-Current Assets | |||||
| PPE Net | 251,977 | 249,753 | 253,939 | 251,154 | 243,728 |
| Intangibles | 1,412,311 | 1,425,658 | 1,468,589 | 1,479,744 | 1,497,394 |
| Other Non-Current Assets | 352,731 | 360,373 | 364,922 | 355,550 | 369,398 |
| TOTAL | $2,017,019 | $2,035,784 | $2,087,450 | $2,086,448 | $2,110,520 |
| Total Assets | $2,644,259 | $2,670,424 | $2,736,017 | $2,703,867 | $2,721,170 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 31,644 | 33,120 | 31,559 | 37,968 | 28,895 |
| Accrued Expenses | 85,801 | 81,137 | 63,065 | 74,704 | 62,119 |
| Other current liabilities | 34,082 | 30,347 | 30,883 | 30,081 | 33,746 |
| TOTAL | $169,204 | $161,256 | $142,128 | $159,379 | $149,820 |
| Non-Current Liabilities | |||||
| Long Term Debt | 330,000 | 300,000 | 300,000 | 319,000 | 389,000 |
| Other Non-Current Liabilities | 95,106 | 92,953 | 105,222 | 100,775 | 104,309 |
| TOTAL | $457,030 | $430,676 | $455,239 | $475,638 | $556,975 |
| Total Liabilities | $626,234 | $591,932 | $597,367 | $635,017 | $706,795 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 156,767 | 158,088 | 158,892 | 158,600 | 157,585 |
| Common Shares | 1,568 | 1,579 | 1,589 | 1,582 | 1,576 |
| Retained earnings | 1,196,385 | 1,286,699 | 1,341,175 | 1,325,247 | 1,297,688 |
| Other shareholders' equity | -82,052 | -85,650 | -60,087 | -78,316 | -75,307 |
| TOTAL | $2,018,025 | $2,078,492 | $2,138,650 | $2,068,850 | $2,014,375 |
| Total Liabilities And Equity | $2,644,259 | $2,670,424 | $2,736,017 | $2,703,867 | $2,721,170 |